Low-dose metronomic oral dosing of a prodrug of gemcitabine (LY2334737) causes antitumor effects in the absence of inhibition of systemic vasculogenesis (Q30523830)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Low-dose metronomic oral dosing of a prodrug of gemcitabine (LY2334737) causes antitumor effects in the absence of inhibition of systemic vasculogenesis |
scientific article |
Statements
1 reference
Low-dose metronomic oral dosing of a prodrug of gemcitabine (LY2334737) causes antitumor effects in the absence of inhibition of systemic vasculogenesis (English)
1 reference
Giulio Francia
1 reference
Yuval Shaked
1 reference
Kae Hashimoto
1 reference
John Sun
1 reference
Melissa Yin
1 reference
Carolyn Cesta
1 reference
Ping Xu
1 reference
Shan Man
1 reference
Christina Hackl
1 reference
Julie Stewart
1 reference
Mark Uhlik
1 reference
Anne H Dantzig
1 reference
F Stuart Foster
1 reference
Robert S Kerbel
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference